Conjugation of Synthetic Polyproline Moietes to Lipid II Binding Fragments of Nisin Yields Active and Stable Antimicrobials by Deng, Jingjing et al.
fmicb-11-575334 November 16, 2020 Time: 15:16 # 1
ORIGINAL RESEARCH















This article was submitted to
Antimicrobials, Resistance
and Chemotherapy,
a section of the journal
Frontiers in Microbiology
Received: 23 June 2020
Accepted: 30 October 2020
Published: 20 November 2020
Citation:
Deng J, Viel JH, Kubyshkin V,
Budisa N and Kuipers OP (2020)
Conjugation of Synthetic Polyproline
Moietes to Lipid II Binding Fragments




Conjugation of Synthetic Polyproline
Moietes to Lipid II Binding
Fragments of Nisin Yields Active and
Stable Antimicrobials
Jingjing Deng1, Jakob H. Viel1, Vladimir Kubyshkin2,3, Nediljko Budisa2,3 and
Oscar P. Kuipers1*
1 Department of Molecular Genetics, University of Groningen, Groningen, Netherlands, 2 Institute of Chemistry, Technical
University of Berlin, Berlin, Germany, 3 Department of Chemistry, University of Manitoba, Winnipeg, MB, Canada
Coupling functional moieties to lantibiotics offers exciting opportunities to produce novel
derivatives with desirable properties enabling new functions and applications. Here, five
different synthetic hydrophobic polyproline peptides were conjugated to either nisin
AB (the first two rings of nisin) or nisin ABC (the first three rings of nisin) by using
click chemistry. The antimicrobial activity of nisin ABC + O6K3 against Enterococcus
faecium decreased 8-fold compared to full-length nisin, but its activity was 16-fold
better than nisin ABC, suggesting that modifying nisin ABC is a promising strategy to
generate semi-synthetic nisin hybrids. In addition, the resulting nisin hybrids are not
prone to degradation at the C-terminus, which has been observed for nisin as it can be
degraded by nisinase or other proteolytic enzymes. This methodology allows for getting
more insight into the possibility of creating semi-synthetic nisin hybrids that maintain
antimicrobial activity, in particular when synthetic and non-proteinaceous moieties are
used. The success of this approach in creating viable nisin hybrids encourages further
exploring the use of different modules, e.g., glycans, lipids, active peptide moieties, and
other antimicrobial moieties.
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INTRODUCTION
Nisin is the first discovered and the best studied lantibiotic and it is produced by Lactococcus
lactis (Rogers, 1928). In addition to its natural presence in fermented foods, nisin has been
applied as a food preservative for many decades, because of its excellent activity against
food spoilage (Hansen and Sandine, 1994; Gharsallaoui et al., 2016). Beyond its role in
food safety and preservation, nisin has potential therapeutic applications. It is for instance
effective against many Gram-positive antibiotic-resistant organisms, such as methicillin-resistant
Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) (Shin et al., 2016).
The exceptional activity of nisin is derived from a unique structure, containing one lanthionine
and four methyllanthionine rings, which has a dual mode of action. The first two rings (AB)
form a lipid II recognition site. By binding to the peptidoglycan precursor lipid II, nisin
inhibits cell wall biosynthesis. The last two rings (DE), which are connected to rings ABC
through a hinge region, constitute a membrane insertion domain. After rings AB dock to
lipid II (Brötz et al., 1998), rings DE and the tail can insert into the bacterial membrane
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to create pores, where nisin forms pores (Lubelski et al., 2008).
Nisin’s dual mode of action increases its antimicrobial activity,
and decreases the chance of resistance development in target
organisms. These features make nisin an attractive candidate for
development into an antibiotic alternative. Unfortunately, nisin
is readily degraded in the gut, which precludes oral delivery.
Also, the administering of nisin by injection, especially at its
full-length, is limited by the instability of its dehydro-residues.
If possible, these problems should be addressed to broaden the
scope of nisin application in the therapeutic setting. A promising
strategy to achieve this has been provided by the chemical
coupling of specific (protease resistant) moieties to nisin, and
semi-synthetic fragments of nisin. This approach allows for
the synthesis of novel derivatives with useful properties like
increased stability, alleviating some of nisin’s characteristics that
are problematic in its potential role as an antibiotic alternative.
The coupling of peptides to compatible moieties can be
achieved through the widely used click chemistry method
(Ahmad Fuaad et al., 2013). “Copper (I)-catalyzed azide-
alkyne cycloaddition (CuAAC)” is the most common reaction
representing the click chemistry. It is a region selective
copper (I) catalytic cycloaddition reaction between an azide
and an alkyne leading to the formation of a triazole.
The molecules connected to the respective reagents are
effectively “clicked” together (Kolb et al., 2001). Due to its
reliability, specificity, biocompatibility, easiness to perform,
and mild reaction conditions, click chemistry is being used
increasingly in diverse areas, such as bioconjugation, drug
design and polymer science (Thirumurugan et al., 2013;
McKay and Finn, 2014; Jiang et al., 2019). The success of
click chemistry in the field of peptide modification can be
attributed to the resulting triazole ring which resembles an
amide bond, and which increases the stability of the resulting
molecule. This is achieved at least in part by increasing the
molecule’s resistance to proteases, as the triazole aligns with
the biological targets through hydrogen bonding and dipole
interactions (Ahmad Fuaad et al., 2013). Peptide coupling
through click chemistry has been the subject of several studies
toward the development of target-specific bacterial probes and
expanding application possibilities of this method (Arnusch,
2008; Yoganathan et al., 2011; Oldach et al., 2012; Slootweg
et al., 2013a, 2014; Koopmans et al., 2015; Bolt et al., 2018).
A prominent example of applying click chemistry to enhance
lantibiotics, is that of coupling nisin AB to lipid moieties
(Koopmans et al., 2015). The resulting hybrid molecules
exhibited increased stability, as well as potent antimicrobial
activity against drug-susceptible and -resistant strains of
Gram-positive bacteria. In other studies, the lipid II-binding
motif (rings AB) of nisin has been conjugated with various
functional molecules (Arnusch, 2008; Koopmans et al., 2015;
Bolt et al., 2018).
Here, a range of experiments was designed for the synthesis of
nisin hybrids by coupling specific synthetic polyproline peptides,
some of which containing cationic residues, to either nisin
AB or nisin ABC. These polyproline peptides (Figure 1) were
designed based on a polyproline structural skeleton using a
proline analog [(2S,3aS,7aS)-octahydroindole-2-carboxylic acid,
Oic] to display a linear and hydrophobic structure affine to a
lipid membrane (Kubyshkin and Budisa, 2018; Kubyshkin et al.,
2019). The selected properties of these nisin hybrids should
aid in the membrane translocation of their C-terminal region
and, as the molecular weight of the clicked polyproline moieties
ranges between 0.5 and 1.5 kDa, the resulting molecules remain
well under nisin in size. Hypothetically, the lipid-II targeting
nisin AB would guide the conjugate to the bacterial membrane,
where the hydrophobic tail would flip into the membrane core,
tightly anchoring the conjugate. The newly synthesized nisin
hybrids were compared to nisin with regard to their antimicrobial
activity, and susceptibility to proteolytic degradation.
MATERIALS AND METHODS
Bacterial Strains and Plasmids
Indicator strains and plasmids used in this work are given in
Table 1.
Preparation of Nisin AB-Azide
Nisin AB was purified in accordance with protocols reported
previously (Slootweg et al., 2013b). Briefly, nisin (180 mg)
was dissolved in 150 mL Tris buffer (5 mmol Tris acetate,
5 mmol CaCl2, 25 mmol sodium acetate, pH 7.0) and the
solution was cooled on ice for 15 min. Then trypsin (15 mg)
was added and warmed up to room temperature for 15 min.
The reaction was performed at 30◦C for 16 h and an extra
15 mg trypsin was added. After 24 h incubation, another
15 mg trypsin was added and the reaction was performed
for another 24 h. The reaction mixture was acidified with
hydrochloric acid (1 M) to pH 4.0 followed by adding
3 mL acetonitrile and concentrated in vacuo. The pure
nisin AB was purified from the mixture by RP-HPLC with
the water-acetonitrile gradient mobile phase containing
trifluoroacetic acid (0.1%) and lyophilized to obtain a white
powder (20 mg). Nisin AB (10 mg, 8.6 µmol) was dissolved in
N,N-dimethylformamide (DMF) (100 µl) and azidopropylamine
(44 µl, 43.2 mg, 432 µmol), N,N-diisopropylethylamine
(DIPEA, 6 µl, 34.8 µmol), and (benzotriazol-1-yloxy)-
tris-(dimethylamino) phosphonium hexafluorophosphate
(BOP, 7.6 mg, 17.2 µmol) or (benzotriazol-1-yl-oxy)-tris-
(pyrrolidino)phosphonium hexafluorophosphate (PyBOP,
9 mg, 17.2 µmol) were added. The reaction was vortexed
for 20 min and subsequently quenched with 5 mL buffer
(water : acetonitrile, 95:5 vol+ 0.1% trifluoroacetic acid). The
reaction mixture was purified by RP-HPLC with the water-
acetonitrile gradient mobile phase containing trifluoroacetic
acid (0.1%) and pure nisin AB-azide was lyophilized to obtain a
white powder (8 mg).
Preparation of Nisin ABC-Azide
α-chymotrypsin was used to digest nisin to generate nisin
ABC. Nisin (180 mg) was dissolved in 150 mL Tris buffer
(25 mmol Tris acetate, pH7.5) and the solution was cooled
on ice for 15 min. Then α-chymotrypsin (15 mg) was
added and warmed up to room temperature for 15 min.
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FIGURE 1 | Structure of the hydrophobic polyproline peptides O3, O6, O9, O3K3, and O6K3 for putative membrane anchoring. The peptides were constructed with
a hydrophobic proline analog (2S,3aS,7aS)-octahydroindole-2-carboxylic acid (Oic, designated as O) and lysine residues (Lys, K).
TABLE 1 | Strains and plasmids used in this work.
Indicator strains Characteristics References
Micrococcus flavus Lab collection
Lactococcus lactis NZ9000 Lab collection
Staphylococcus aureus MW2 Methicillin resistant (MRSA) The University Medical Center
Groningen, The Netherlands
Enterococcus faecium LMG 16003 Avaparicin and vancomycin resistant (VRE) Laboratory of Microbiology, Gent,
Belgium
Listeria monocytogenes LMG 10470 Montalbán-López et al., 2018
Plamids Characteristics References
pEmpty pNZ8048, pSH71 origin of replication, PnisA promoter and empty multiple
cloning site, chloramphenicol resistance
Kuipers et al., 1998
pNSR pNZ-SV-SaNSR, pSH71 origin of replication, expression of nsr under the
control of PnisA promoter, chloramphenicol resistance
Khosa et al., 2013, 2016
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The enzymatic digestion was performed same as described
for nisin AB. Nisin ABC was purified from the mixture
by RP-HPLC with the water-acetonitrile gradient mobile
phase containing trifluoroacetic acid (0.1%) and then
lyophilized to obtain a white powder (20 mg). Nisin
ABC (10 mg, 6.5 µmol) was dissolved in DMF (50 µl).
The azide-coupling reaction was performed same as
described for nisin AB.
Preparation of the Hydrophobic
Polyproline Peptides
The polyproline-containing peptides were prepared using
a manual Fmoc-based solid-phase peptide synthesis
scheme as described (Kubyshkin and Budisa, 2018).
The sequences were grown on 2-clorotrityl resins pre-
loaded with either Fmoc-Oic-OH or Fmoc-Lys (Boc)-OH
(Fmoc = fluorenylmethyloxycarbonyl, Boc = tert-
butyloxycarbonyl). The resin loading was estimated at
0.7–0.8 mmol/g. The synthesis was performed in DMF
using 2.5 equiv. of the Fmoc-amino acid pre-activated
with the mixture of 2.5 equiv. 2-(1H-benzotriazole-1-yl)-
1,1,3,3-tetramethylaminium tetrafluoroborate (TBTU) and
2.5 equiv.1-hydroxybenzotriazole (HOBt) mixture under
addition of 5 equiv. DIPEA. The N-terminal pentynyl
moiety was installed under coupling with pentynoic acid
under same activation conditions. The Fmoc group was
removed by treatment with 22 vol% piperidine in DMF. The
final peptides were cleaved off the resin by treatment with
hexafluoroisopropanol : dichloromethane (1:3, vol: vol) mixture.
The peptides were additionally purified on short silica gel
columns using dichloromethane-methanol gradient elution.
Pentynyl-(Oic)9-OH (O9) peptide was additionally purified
by precipitation from methanol. The Boc-group was removed
from the lysine side-chains by treatment with 4 M hydrogen
chloride in dioxane. The identity and purity of the final peptides
were confirmed by mass-spectra (ESI-Orbitrap) and 1H-NMR
spectra (CD3OD, 700 MHz). The peptides were obtained in
10–50 mg quantities.
Click Chemistry
A stock solution of CuSO4 (10 mg, 100 mM), sodium ascorbate
(200 mg, 1 M) 2-(4-((bis((1-(tert-butyl)-1H-1,2,3-triazol-4-
yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)-acetic acid
(BTTAA, 25 mg, 50 mM), and tris((1-hydroxy-propyl-1H-
1,2,3-triazol-4-yl)methyl)amine (THPTA, 25 mg, 250 mM) in
deionized water and a stock solution of O3 (1 mg, 36 mM),
O6 (1.8 mg, 36 mM), O9 (2.6 mg, 36 mM), O3K3 (1.9 mg,
36 mM) and O6K3 (2.7 mg, 36 mM) in DMF (50 µl)
were prepared, aliquoted and stored at −20◦C for further
use. Firstly, nisin AB-azide (25 µg, 0.02 µmol) or nisin
ABC-azide (40 µg, 0.02 µmol) were dissolved in 100 mM
phosphate buffer (pH7.0, final reaction volume: 200 µl).
Then, the appropriate O3, O6, O9, O3K3, or O6K3 (5 µl,
0.18 µmol) and CuSO4 (4 µl, 0.4 µmol) : THPTA (8 µl,
2 µmol) or BTTAA (40 µl, 2 µmol)-premix were added
followed by the addition of sodium ascorbate (20 µl, 20
µmol). The reaction was performed at 37◦C for 1 h and
purified directly by RP-HPLC with the water-acetonitrile
gradient mobile phase containing trifluoroacetic acid (0.1%).
The pure product-containing fractions were lyophilized to
obtain nisin hybrids 6–15 as white fluffy powders (Figure 2).
The reaction was further scaled up in ratio to obtain more
products.
Agar Well Diffusion Assay
Agar well diffusion assay against Micrococcus flavus was
performed as described previously (van Heel et al., 2013). 0.15
nmol of each sample was added to each well. The agar plate was
incubated at 30◦C overnight, after which the zone of inhibition
was measured.
Determination of the Minimal Inhibitory
Concentration (MIC)
All samples were resuspended in 0.05% aqueous acetic acid
solution and the peptide amount was quantified by HPLC
according to Schmitt et al. (Schmitt et al., 2019). The
indicator strains MW2-MRSA, Enterococcus faecium, Listeria
monocytogenes, and Lactococcus lactis were first streaked on
GM17 plate and cultured overnight. The peptide samples were
diluted with 0.05% acetic acid to a concentration of 40–320 µM
(depending on the estimated activity of the peptide and the strain
tested). The MIC value test was performed according to Wiegand
et al. (2008).
RESULTS
Production of Nisin AB-Azide and Nisin
ABC-Azide
Nisin was digested using trypsin and chymotrypsin, respectively,
to generate nisin AB and nisin ABC fragments (Figure 2).
The desired truncated nisin molecules were purified from
the digestion mixture with yields in the milligram range,
in accordance with protocols reported previously (Slootweg
et al., 2013b). After purification, an azide linker was added
to the C-terminus of the acquired nisin fragments. Since
the truncated variants with the azide linker were needed in
relatively large quantities for the generation of the semi-
synthetic analogs, the previously reported peptide coupling
procedure was optimized for this study. Initially, addition of
the azide linker was done by coupling azidopropylamine to
nisin AB in the presence of BOP as the coupling reagent.
HPLC analysis of the reactions performed under these conditions
showed substantial amounts of substrate remained unreacted,
resulting in a reaction efficiency of only 7.4% (Supplementary
Figure 1). Prolonging the reaction time to 1 h did not increase
the conversion. However, by substituting the coupling reagent
BOP for PyBOP, the reaction efficiency could be increased
to 89% (Supplementary Figure 1). For reactions of this
nature, PyBOP was shown to be a better coupling reagent
than to BOP. Using the optimized conditions from the above
experiment, azidopropylamine was coupled to nisin AB and
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FIGURE 2 | Nisin digestion and semi-synthesis of nisin AB and nisin ABC conjugates. (a) Trypsin, Tris buffer, pH 7.0, 30◦C, 48 h; (b) chymotrypsin, Tris buffer, pH
7.5, 30◦C, 48 h; (c) azidopropylamine, PyBOP, DIPEA, DMF, RT, 20 min; (d) CuSO4, BTTAA, sodium ascorbate in phosphate buffer, 37◦C, 1 h.
nisin ABC in a reaction containing PyBOP/DIPEA to give
nisin AB-azide and nisin ABC-azide in 89 and 87% yield,
respectively, which was purified by HPLC and characterized
by MALDI-TOF. The resulting nisin AB-azide and nisin ABC-
azide contain convenient handles for ligation to alkynes via
CuAAC.
Production of Nisin AB and Nisin ABC
Conjugates
Five hydrophobic polyproline peptides (1–5) were coupled to
nisin AB-azide and nisin ABC-azide (Figure 2). The first
click reaction was attempted with O3 (1) and nisin AB-azide
in the presence of THPTA as copper (I)-stabilizing ligand.
Analysis by HPLC showed that a good amount of product
was formed under these reaction conditions. Increasing the
reaction temperature to 50◦C and extending the reaction time
to 2 h led to degradation rather than increased conversion. The
conversion could however be increased by using BTTAA as
substitute for THPTA as copper (I)-stabilizing ligand improved
the conversion. The best results were obtained using 9 equiv.
O3, 20 equiv. CuSO4, 100 equiv. BTTAA and 1,000 equiv.
sodium ascorbate, reacted at 37◦C for 1 h. Under these
optimized conditions, the click reaction of nisin AB-azide and
nisin ABC-azide with the five hydrophobic polyproline peptides
(1–5) were carried out successfully to give semi-synthetic nisin
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FIGURE 3 | Antimicrobial activity of semi-synthetic nisin hybrids against M. flavus by agar well diffusion assay. 1: Nisin; 2: Nisin AB; 3: Nisin ABC; 4: Nisin AB-azide;
5: Nisin ABC-azide; 6: O3; 7: O6; 8: O9; 9: O3K3; 10: O6K3; 11: Nisin AB + O3; 12: Nisin AB + O6; 13: Nisin AB + O9; 14: Nisin AB + O3K3; 15: Nisin AB + O6K3;
16: Nisin ABC + O3; 17: Nisin ABC + O6; 18: Nisin ABC + O9; 19: Nisin ABC + O3K3; 20: Nisin ABC + O6K3.
TABLE 2 | MIC value (µM) of nisin AB and nisin ABC conjugates.
Peptides MW2-MRSA E. faecium L. monocytogenes L. lactis NZ9000 (pEmpty) L. lactis NZ9000 (pNSR)
Nisin 5.0 0.31 2.5 0.16 2.5
O3 >320 >320 >320 >320 ND
O6 >320 >320 >320 >320 ND
O9 >320 >320 >320 >320 ND
O3K3 >160 >160 >160 >160 ND
O6K3 >80 >80 >80 >80 ND
Nisin AB >320 160 >320 >40 ND
Nisin AB + O3 ND ND ND >40 ND
Nisin AB + O6 ND ND ND 20 ND
Nisin AB + O9 ND ND ND 5.0 ND
Nisin AB + O3K3 ND ND ND >40 ND
Nisin AB + O6K3 ND ND ND 10 ND
Nisin ABC 40 40 40 5.0 ND
Nisin ABC + O3 >80 20 >80 5.0 ND
Nisin ABC + O6 80 5 20 5.0 5.0
Nisin ABC + O9 >80 10 40 5.0 ND
Nisin ABC + O3K3 80 40 80 2.5 ND
Nisin ABC + O6K3 80 2.5 10 2.5 2.5
In red: MIC values that are improved in comparison to one of nisinAB or nisin ABC. In blue: the effect of the nisinase presence is depicted. ND: not determined.
hybrids 6–15 in 42–54% yields. The resulting semi-synthetic
nisin hybrids 6–15 were further characterized by MALDI-
TOF.
Antimicrobial Activity of Nisin AB and
Nisin ABC Conjugates
To investigate the biological activity of the nisin hybrids, an
agar well diffusion assay and a growth inhibition assay were
performed. M. flavus was used as the indicator strain for the
agar well diffusion assay, and 0.15 nmol of each sample was
added to each well (Figure 3). The results showed that nisin
AB and five hydrophobic polyproline moieties (1–5) are not
active alone and nisin has the highest activity. Of the nisin AB
conjugates, nisin AB + O6K3 is the only active one. Notably,
with the exception of nisin ABC + O9, all four nisin ABC
conjugates showed activity. Most notably the activity of nisin
ABC + O3K3 is considerably higher than that of nisin ABC.
Antimicrobial activity of all compounds was tested by growth
inhibition assays against two clinically relevant Gram-positive
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pathogens, i.e., methicillin resistant S. aureus and vancomycin
resistant E. faecium, as well as L. monocytogenes, and L. lactis.
Their minimal inhibitory concentration (MIC) was determined
using an established broth microdilution assay (Table 2), using
nisin as a positive control. Nisin AB was devoid of activity
at the highest concentration tested except against E. faecium.
Since of the nisin AB conjugates only nisin AB + O6K3 showed
activity in the agar well diffusion assay, they were only tested
against L. lactis. In this growth inhibition assay, nisin AB + O9
showed the best activity among the five nisin AB conjugates.
Nisin ABC conjugates displayed a retained or even increased
activity against E. faecium and L. lactis compared to nisin ABC
alone, whereas activity against MW2-MRSA diminished. The
antimicrobial activity of nisin ABC + O6K3 against E. faecium,
L. monocytogenes, and L. lactis decreased only 8-, 4-, and 12-fold
compared to full nisin, respectively. Strikingly, its antimicrobial
activity against E. faecium, L. monocytogenes, and L. lactis
increased 16-, 4-, and 2-fold compared to nisin ABC, respectively,
and increased all twice compared to nisin ABC + O6, respectively.
Compared to nisin ABC, nisin ABC + O6K3 displayed improved
activity against E. faecium, L. monocytogenes, and L. lactis
but decreased activity against MW2-MRSA while nisin ABC
+ O9 showed enhanced activity against E. faecium although
activity against other strains was retained or even reduced.
An additional test was performed to assess if the resistance
to proteolytic degradation of the semi-synthetic nisin hybrids
had improved compared to the parent compound. Nisin, nisin
ABC + O6K3, and nisin ABC + O6 were exposed to the nisin
resistance protein (NSR), a peptidase that cleaves the linear
C-terminus of nisin. For this experiment, an activity test was
performed against the NSR producing strain L. lactis NZ9000
(pNSR). In this test, NSR conferred its producing strain over 16-
fold resistance toward nisin in MIC, caused by the proteolytic
cleavage at the C-terminal tail of nisin. The hybrids Nisin ABC
+ O6K3 and nisin ABC + O6 bypassed this nisin resistance
mechanism, having identical MICs against NZ9000 regardless of
it producing NSR.
DISCUSSION
In this research, an efficient and direct method for the
preparation of nisin hybrids was developed. Nisin AB and
nisin ABC fragments were obtained by enzymatic digestion
of nisin and these fragments were subsequently C-terminally
functionalized with azidopropylamine. Five hydrophobic
polyproline peptides (without and with cationic residues) were
synthesized and coupled to nisin AB-azide and nisin ABC-azide
by using click chemistry. Ten newly synthesized nisin hybrids
were obtained and their antimicrobial activities were tested.
The agar diffusion assay showed that the activity of nisin
ABC conjugates are much better than nisin AB conjugates.
These results are in line with previous studies that showed that
variants lacking ring C, or where ring C is not closed, lack
antimicrobial activity (Chan et al., 1996). It is noteworthy that
while nisin AB is inactive having a lysine at the C-terminus, it
gains higher activity through conjugation with O6K3 than with
the more hydrophobic O6. The growth inhibition experiments
showed that the activity of nisin ABC + O6K3 are better than
nisin ABC + O6 and nisin ABC + O9, again indicating that
addition of lysines (positive charge) at the C-terminal region
can improve the activity. The antimicrobial activity of nisin
ABC + O6K3 against E. faecium was 8-fold less active than
full-length nisin. However, the activity was 16-fold better than
nisin ABC, suggesting that modifying nisin ABC is a promising
strategy to generate semi-synthetic nisin hybrids. It is notable
that the inhibition activities of the semi-synthetic hybrids did
not fully correlate when comparing solid media tests and broth
MIC tests. However, this effect has been described for many
nisin mutants, e.g., nisin A and nisin Z (de Vos et al., 1993).
These compounds have an identical MIC, but a single amino
acid difference leads to different halo sizes on diffusion assays,
which is likely caused by altered diffusion properties. The five
polyproline moieties that were tested in this study have varying
hydrophobicities. Therefore, the lack of correlation between
both essay results are likely caused by their distinct diffusion
characteristics. In addition to their increased activity, these
variants are not prone to degradation at the C-terminus by NSR,
as was observed for nisin. Although the full proteolytic resistance
of the conjugates was not tested, polyproline chains commonly
have resistance against proteolysis in general, and convey this
property to the nisin hybrids, providing a proof of concept.
Notably, the method described in this study can be applied to
conjugate other compatible (synthetic and non-proteinaceous)
moieties that can provide the desired resistance to specific
proteases. Nisin AB-azide and nisin ABC-azide can be readily
generated with yields in the milligram range according to our
optimized protocol. Future studies may focus on coupling
peptides, especially anti-Gram-negative peptides, with nisin
ABC-azide. Overall, this study highlights how lantibiotic
fragments can be used as lead structures to create novel variants
with altered properties (e.g., stability, activity, and specificity) via
chemical coupling.
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